Targacept (TRGT)

Add to Watchlists
Create an Alert
4.38 +0.29  +7.09% NASDAQ Apr 22, 8:00PM BATS Real time Currency in USD
View Full Chart
TRGT Price Chart
View All Events

TRGT Events

Date Type Description
Feb 13 Misc Targacept, Inc. Q4 2013 Earnings Conference Call
Feb 13 Earnings Targacept, Inc. Q4 2013 Earnings Results. Estimate: -0.37.
Nov 05 Misc October 29, 2013 Targacept to Report Third Quarter 2013 Financial Conference Call
Nov 05 Earnings October 29, 2013 Targacept to Report Third Quarter 2013 Financial Results on November 5, 2013. Estimate: -0.39.
Aug 06 Misc Second Quarter 2013 Financial Conference Call
Aug 06 Earnings July 30, 2013 Targacept to Report Second Quarter 2013 Financial Results on August 6, 2013. Estimate: -0.37.
May 31 Misc AGM Event for Targacept Inc
May 07 Misc Targacept to Report First Quarter 2013 Financial Results on May 7, 2013
May 07 Earnings April 30, 2013 Targacept to Report First Quarter 2013 Financial Results on May 7, 2013. Estimate: -0.29.
View All Performance Charts

TRGT Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Targacept is down 0.45% over the last year vs S&P 500 Total Return up 22.85%, Repligen up 81.91%, and Jazz Pharmaceuticals up 163.5%.

Get Quote for
Advertisement

Portfolio Strategies Featuring TRGT

Did Targacept make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

TRGT Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: North Carolina
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Targacept, Inc. is a biopharmaceutical company. It is engaged in the design, discovery and development of a new class of drugs to treat multiple diseases and disorders of the nervous system by selectively targeting neuronal nicotinic receptors, or NNRs. Targacept provides treatment options for complex diseases and disorders to improve the lives of patients by developing medicines that exploit the unique role of NNRs. The company was founded by J. Donald deBethizy, Merouane Bencherif, William S. Caldwell and Patrick M. Lippiello in March 1997 and is headquartered in Winston-Salem, North Carolina.

Recent Quotes

Symbol Price Chg Chg % Market Cap
TRGT 4.38 +0.29 +7.09% 147.80M
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.